Neurocrine Biosciences (NBIX) Presents At 40th Annual J.P. Morgan Virtual Healthcare Conference

J.P. Morgan Healthcare Conference January 2022 Safe Harbor Statement 2 In addition to historical facts, this presentation contains forward-looking statements that involve a number of risks and uncertainties. These statements include, but are not limited to, statements related to: the benefits to be derived from our products and product candidates; the value our products and/or our product candidates may bring to patients; the continued success of INGREZZA; our financial and operating performance, including ...